SIGMA LABS, INC (OTCMKTS:SGLB) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 14, 2017, Sigma Labs, Inc. (“we,” “our,” “us” or the “Company”) entered into an employment letter agreement with Nannette Toups, effective September 28, 2017 (the "Effective Date"), to which Ms. Toups has agreed to serve as our Chief Financial Officer, Treasurer, principal accounting officer, principal financial officer and Secretary on an "at-will" basis.

Under the employment letter agreement, Ms. Toups is entitled to (i) an annual base salary of $110,000 (such base salary is not subject to decrease, but may be increased in the discretion of the Company’s Compensation Committee of the Board of Directors based on an annual assessment of Ms. Toups' performance and other factors), (ii) all benefits that we elect in our sole discretion to provide from time to time to our other executive officers, and (iii) a grant under our 2013 Equity Incentive Plan of (1) a five-year stock option to purchase up to 2,500 shares of common stock of the Company, which will have an exercise price equal to the closing price of the Company's common stock on the Effective Date, and will vest and become exercisable in full on the Effective Date, and (2) a five-year stock option to purchase up to 47,500 shares of common stock of the Company, which will have an exercise price equal to the closing price of the Company's common stock on the Effective Date, and will vest and become exercisable as follows: 3,065 shares will vest and become exercisable on the one-year anniversary of the Effective Date, 7,125 shares will vest and become exercisable on the second-year anniversary of the Effective Date, 11,185 shares will vest and become exercisable on the third-year anniversary of the Effective Date, and 26,125 shares will vest and become exercisable on the fourth-year anniversary of the Effective Date, provided, in each case, that Ms. Toups' remains an employee of the Company through such vesting date. The options will be on such other terms and provisions as are contained in the Company's standard form nonqualified stock option agreement.

Since December 2013, Ms. Toups has served as a contract CFO and provided accounting services to a variety of clients in different industries ranging from non-profits to medical device development. From May 2008 to October 2013, Ms. Toups served in various positions at Qforma, Inc., a privately-held custom software development company, including as Controller and most recently as Senior Vice-President of Finance and Administration. Prior to joining Qforma, she served as an independent consultant from October 2005 to May 2008, providing a variety of financial, accounting and management services to individuals, entrepreneurs and a non-profit organization. From May 2004 to September 2005, Ms. Toups served as the Controller of KSL Joint Venture, where she was responsible for all accounting and financial reporting activities for the Site Support Services Group at Los Alamos National Laboratory. From January 2002 to April 2003, she served as the Controller and Treasurer of BiosGroup, Inc., a closely-held complexity science consulting company. Prior thereto, Ms. Toups served in various positions at Louisiana Intrastate Gas Company, LLC, including Controller and Transition Projects Manager. Ms. Toups received her CPA certification in 1984 and holds a bachelor’s degree in business administration and accounting from Louisiana State University, and a master’s of liberal arts degree from St. John’s College.

Ms. Toups, age 61, has no family relationship with any of the Company’s officers and directors.

Murray Williams, our current Chief Financial Officer, Treasurer, principal accounting officer and principal financial officer, agreed to resign from such positions effective September 28, 2017, prior to Ms. Toups' appointment. Mr. Williams and the Company intend to enter into a consulting agreement under which Mr. Williams will continue to provide services to the Company on an as needed basis.

On September 18, 2017, the Company and Ronald Fisher, the Company's Vice President of Business Development, entered into Amendment No. 1 to Mr. Fisher's Employment Offer Letter Agreement, effective August 10, 2015, to which, effective as of February 11, 2017, item 2, entitled "Performance Bonuses," of Exhibit A of Mr. Fisher's Employment Offer Letter Agreement was deleted in its entirety and replaced with the new item 2 that is set forth in the amendment to Employment Offer Letter Agreement. Under the amendment, Mr. Fisher will be entitled to receive performance-based stock and cash bonuses if certain milestones are satisfied by February 11, 2018, so long as Mr. Fisher remains an employee of the Company as of the date the applicable milestone is satisfied.

The Employment Letter Agreement and Amendment No. 1 to Employment Offer Letter Agreement are filed hereto as Exhibits 10.1 and 10.2, respectively, and are incorporated into this Item 5.02 by reference. The foregoing descriptions of the Employment Letter Agreement and Amendment No. 1 to Employment Offer Letter Agreement are qualified in their entirety by reference to the full text of the Employment Letter Agreement and Amendment No. 1 to Employment Offer Letter Agreement, as applicable.

On September 20, 2017, the Company and Amanda Cola, our Vice President of Finance and Business Operations, agreed to terminate Ms. Cola's employment with the Company, effective October 2, 2017.

Item 8.01Other Events.

As previously reported, on July 26, 2017, we received a notice from Nasdaq acknowledging the fact that we do not meet the requirements of Nasdaq Listing Rule 5605. The notice stated that (i) we had 45 calendar days to submit to Nasdaq a plan to regain compliance with Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2), and (ii) to regain compliance with Nasdaq Listing Rule 5605(d)(2), we (a) had until the earlier of our next annual shareholders’ meeting or July 24, 2018, or (b) if our next annual shareholders' meeting is held before January 22, 2018, then we had to evidence compliance no later than January 22, 2018.

On September 18, 2017, Nasdaq notified us that, based on its review of our plan of compliance, Nasdaq has determined to grant the Company an extension until January 22, 2018 to regain compliance with Nasdaq Listing Rules by appointing at least one more independent director to our Board of Directors and Audit Committee. If compliance cannot be demonstrated by January 22, 2018, Nasdaq will provide written notification that our securities will be delisted. In the event of such a notification, we may appeal Nasdaq's determination. Our Board of Directors intends to appoint at least one more independent director to our Board of Directors and Audit Committee prior to January 22, 2018.

In addition, Nasdaq notified us on September 18, 2017 that it had determined that we have regained compliance with Nasdaq Listing Rule 5605(d)(2) as a result of our appointment of two independent directors to our Compensation Committee.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.

SIGMA LABS, INC. Exhibit
EX-10.1 2 f8k091917_ex10z1.htm EXHIBIT 10.1 EMPLOYMENT LETTER AGREEMENT Exhibit 10.1 Employment Letter Agreement   September 12,…
To view the full exhibit click here

About SIGMA LABS, INC (OTCMKTS:SGLB)

Sigma Labs, Inc. is a technology company that specializes in the development and commercialization of manufacturing and materials technologies. The Company’s principal business activities include the development of its In-Process Quality Assurance (IPQA) suite of technologies and the commercialization of both its IPQA and materials-related suite of technologies, with its focus on three-dimensional printing (3DP) industry. It is engaged in a range of activities in which it seeks to commercialize technologies and products in various industry sectors, such as aerospace and defense manufacturing; bio-medical manufacturing; automotive manufacturing, and other markets. It offers PrintRite3D SENSORPAK, which is an auxiliary sensor and hardware kit; PrintRite3D INSPECT, which is a software that verifies quality layer by layer, and PrintRite3D CONTOUR, which is a software that assures the as-built geometry. Its other software modules include PrintRite3D THERMAL and PrintRite3D ANALYTICS.